Juan Carlos
Montero González
Investigador des de 2021
Centro de Investigación Biomédica en Red de Cáncer
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Centro de Investigación Biomédica en Red de Cáncer (8)
2024
-
Differentially Expressed Genes Involved in Primary Resistance to Immunotherapy in Patients with Advanced-Stage Pulmonary Cancer
International Journal of Molecular Sciences, Vol. 25, Núm. 4
-
PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2− breast cancer
Cancer Medicine, Vol. 13, Núm. 17
-
Peptidylarginine deiminase 3 modulates response to neratinib in HER2 positive breast cancer
Oncogenesis, Vol. 13, Núm. 1
2023
-
Analysis of Circulating Tumor DNA in Synchronous Metastatic Colorectal Cancer at Diagnosis Predicts Overall Patient Survival
International Journal of Molecular Sciences, Vol. 24, Núm. 9
2021
-
MZ1 co-operates with trastuzumab in HER2 positive breast cancer
Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1
2020
-
Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple-negative breast cancer
Journal of Cellular and Molecular Medicine, Vol. 24, Núm. 5, pp. 3117-3127
2019
-
Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer
Journal of Experimental and Clinical Cancer Research, Vol. 38, Núm. 1
2017
-
Regulation of the prometastatic neuregulin–MMP13 axis by SRC family kinases: therapeutic implications
Molecular Oncology, Vol. 11, Núm. 12, pp. 1788-1805